BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 28067166)

  • 1. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
    Hanenberg H; Roellecke K; Wiek C
    Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
    Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
    Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Gene Therapy for Fanconi Anemia.
    Río P; Navarro S; Bueren JA
    Hum Gene Ther; 2018 Oct; 29(10):1114-1123. PubMed ID: 30117331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid lentiviral transduction preserves the engraftment potential of Fanca(-/-) hematopoietic stem cells.
    Müller LU; Milsom MD; Kim MO; Schambach A; Schuesler T; Williams DA
    Mol Ther; 2008 Jun; 16(6):1154-60. PubMed ID: 18398427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anchored Lentiviral Vector Episomes for Stem Cell Gene Therapy in Fanconi Anemia.
    Verghese SC; Kurre P
    Curr Gene Ther; 2017; 16(5):329-337. PubMed ID: 28093967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic correction of Fanconi anemia cells in the murine bone marrow after carrier cell mediated delivery of lentiviral vector.
    Chakkaramakkil Verghese S; Goloviznina NA; Kurre P
    Stem Cell Res Ther; 2016 Nov; 7(1):170. PubMed ID: 27865213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal conditioning in Fanconi anemia promotes multi-lineage marrow engraftment at 10-fold lower cell doses.
    Haworth KG; Ironside C; Ramirez MA; Weitz S; Beard BC; Schwartz JD; Adair JE; Kiem HP
    J Gene Med; 2018 Oct; 20(10-11):e3050. PubMed ID: 30129972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral-Mediated Gene Therapy in Fanconi Anemia-A Mice Reveals Long-Term Engraftment and Continuous Turnover of Corrected HSCs.
    Molina-Estevez FJ; Nowrouzi A; Lozano ML; Galy A; Charrier S; von Kalle C; Guenechea G; Bueren JA; Schmidt M
    Curr Gene Ther; 2015; 15(6):550-62. PubMed ID: 26415575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia.
    Río P; Navarro S; Wang W; Sánchez-Domínguez R; Pujol RM; Segovia JC; Bogliolo M; Merino E; Wu N; Salgado R; Lamana ML; Yañez RM; Casado JA; Giménez Y; Román-Rodríguez FJ; Álvarez L; Alberquilla O; Raimbault A; Guenechea G; Lozano ML; Cerrato L; Hernando M; Gálvez E; Hladun R; Giralt I; Barquinero J; Galy A; García de Andoín N; López R; Catalá A; Schwartz JD; Surrallés J; Soulier J; Schmidt M; Díaz de Heredia C; Sevilla J; Bueren JA
    Nat Med; 2019 Sep; 25(9):1396-1401. PubMed ID: 31501599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34
    Río P; Navarro S; Guenechea G; Sánchez-Domínguez R; Lamana ML; Yañez R; Casado JA; Mehta PA; Pujol MR; Surrallés J; Charrier S; Galy A; Segovia JC; Díaz de Heredia C; Sevilla J; Bueren JA
    Blood; 2017 Sep; 130(13):1535-1542. PubMed ID: 28801449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
    Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
    Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons Learned from Two Decades of Clinical Trial Experience in Gene Therapy for Fanconi Anemia.
    Adair JE; Sevilla J; Heredia CD; Becker PS; Kiem HP; Bueren J
    Curr Gene Ther; 2017; 16(5):338-348. PubMed ID: 28103787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors.
    Galimi F; Noll M; Kanazawa Y; Lax T; Chen C; Grompe M; Verma IM
    Blood; 2002 Oct; 100(8):2732-6. PubMed ID: 12351379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroviral mediated gene transfer of the Fanconi anemia complementation group C gene to hematopoietic progenitors of group C patients.
    Liu JM; Young NS; Walsh CE; Cottler-Fox M; Carter C; Dunbar C; Barrett AJ; Emmons R
    Hum Gene Ther; 1997 Sep; 8(14):1715-30. PubMed ID: 9322874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overnight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc-/- stem cells.
    Si Y; Pulliam AC; Linka Y; Ciccone S; Leurs C; Yuan J; Eckermann O; Fruehauf S; Mooney S; Hanenberg H; Clapp DW
    Blood; 2008 Dec; 112(12):4458-65. PubMed ID: 18684868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo proliferation advantage of genetically corrected hematopoietic stem cells in a mouse model of Fanconi anemia FA-D1.
    Río P; Meza NW; González-Murillo A; Navarro S; Alvarez L; Surrallés J; Castella M; Guenechea G; Segovia JC; Hanenberg H; Bueren JA
    Blood; 2008 Dec; 112(13):4853-61. PubMed ID: 18812474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia.
    Román-Rodríguez FJ; Ugalde L; Álvarez L; Díez B; Ramírez MJ; Risueño C; Cortón M; Bogliolo M; Bernal S; March F; Ayuso C; Hanenberg H; Sevilla J; Rodríguez-Perales S; Torres-Ruiz R; Surrallés J; Bueren JA; Río P
    Cell Stem Cell; 2019 Nov; 25(5):607-621.e7. PubMed ID: 31543367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype correction of Fanconi anemia group A hematopoietic stem cells using lentiviral vector.
    Yamada K; Ramezani A; Hawley RG; Ebell W; Arwert F; Arnold LW; Walsh CE
    Mol Ther; 2003 Oct; 8(4):600-10. PubMed ID: 14529833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients.
    Jacome A; Navarro S; Río P; Yañez RM; González-Murillo A; Lozano ML; Lamana ML; Sevilla J; Olive T; Diaz-Heredia C; Badell I; Estella J; Madero L; Guenechea G; Casado J; Segovia JC; Bueren JA
    Mol Ther; 2009 Jun; 17(6):1083-92. PubMed ID: 19277017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector.
    Becker PS; Taylor JA; Trobridge GD; Zhao X; Beard BC; Chien S; Adair J; Kohn DB; Wagner JE; Shimamura A; Kiem HP
    Gene Ther; 2010 Oct; 17(10):1244-52. PubMed ID: 20485382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.